Methyl 6-?Amino-?6-?deoxy-α-?D-?glucopyranoside is an intermediate in synthesizing Ranimustine (R120030), a nitrosourea alkylating agent approved in Japan for the treatment of chronic myelogenous leukemia and polycythemia vera. It can be used in biological study of synthesis of anti-EGFR antibody-drug conjugates. It can also be used in therapeutic use and biological study of BCMA (B-Cell Maturation Antigen) antigen binding proteins.
參考文獻
Choi, H., et al.: PCT Int. Appl., WO 2017051254 A1 20170330 (2017)
滬ICP備17019645號
400-821-0725
